登录 注册 会员服务 联系我们

RhPDCD5 combined with dexamethasone increases antitumor activity in multiple myeloma partially via inhibiting the Wnt signalling pathway

  • Published:2017-11-09 Issue:2 Volume:45 Page:140-145
  • ISSN:0305-1870
  • Container-title:Clinical and Experimental Pharmacology and Physiology
  • language:en
  • Short-container-title:Clin Exp Pharmacol Physiol

Author:

Cheng Qian1,Liu Liping2,Fu Yunfeng1,Zhang Yanan1,Yang Ye3,Liu Jing1ORCID

Affiliation:

1. Department of Hematology; the Third Xiangya Hospital; Central South University; Changsha Hunan China

2. Department of General Surgery; the Affiliated Zhuzhou Hospital; Xiangya Medical College; Central South University; Zhuzhou Hunan China

3. Basic Medical College; Nanjing University of Chinese Medicine; Nanjing Jiangsu China

Funder

National Natural Science Foundation of China

China Scholarship Council

Innovative Research Funds for the Central South University

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Reference30 articles.

1. An update on molecular biology and drug resistance mechanisms of multiple myeloma;Mutlu;Crit Rev Oncol Hematol,2015

2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014

3. Multiple myeloma: the disease and its treatment;Gupta;Int J Basic Clin Pharmacol,2013

4. Epidemiology of Multiple Myeloma

5. Treatment of multiple myeloma: Finding the right combination;Rosenzweig;Oncology (Williston Park),2016

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3